{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:32:25Z","timestamp":1793298745612,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Key Program of National Natural Science Foundation of China","award":["82330055"],"award-info":[{"award-number":["82330055"]}]},{"name":"funding for Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University","award":["2021-LCYJ-PY-16"],"award-info":[{"award-number":["2021-LCYJ-PY-16"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020YFA0710800"],"award-info":[{"award-number":["2020YFA0710800"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019349","name":"Nanjing Medical Science and Technique Development Foundation","doi-asserted-by":"publisher","award":["JQX20004"],"award-info":[{"award-number":["JQX20004"]}],"id":[{"id":"10.13039\/501100019349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-06170-y","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T04:44:12Z","timestamp":1752554652000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Serum untargeted metabolomics alterations in systemic lupus erythematosus patients with elevated serum ferritin"],"prefix":"10.1038","volume":"15","author":[{"given":"Na","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huayong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebing","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyu","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,15]]},"reference":[{"key":"6170_CR1","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41584-023-00948-y","volume":"19","author":"S Fasano","year":"2023","unstructured":"Fasano, S. et al. Precision medicine in systemic lupus erythematosus. Nat. Rev. Rheumatol. 19, 331\u2013342. https:\/\/doi.org\/10.1038\/s41584-023-00948-y (2023).","journal-title":"Nat. Rev. Rheumatol."},{"key":"6170_CR2","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1136\/annrheumdis-2018-214502","volume":"78","author":"D Jesus","year":"2019","unstructured":"Jesus, D. et al. Derivation and validation of the SLE disease activity score (SLE-DAS): A new SLE continuous measure with high sensitivity for changes in disease activity. Ann. Rheum. Dis. 78, 365\u2013371. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214502 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"6170_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1093\/rheumatology\/kew407","volume":"56","author":"C Arriens","year":"2017","unstructured":"Arriens, C. et al. Systemic lupus erythematosus biomarkers: The challenging quest. Rheumatology 56, 32\u201345. https:\/\/doi.org\/10.1093\/rheumatology\/kew407 (2017).","journal-title":"Rheumatology"},{"key":"6170_CR4","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1002\/art.24698","volume":"61","author":"RA Furie","year":"2009","unstructured":"Furie, R. A. et al. Novel evidence-based systemic lupus erythematosus responder index. Arthr. Rheum-Arthr. Care Res. 61, 1143\u20131151. https:\/\/doi.org\/10.1002\/art.24698 (2009).","journal-title":"Arthr. Rheum-Arthr. Care Res."},{"issue":"44","key":"6170_CR5","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1093\/rheumatology\/keh624","volume":"2005","author":"DA Isenberg","year":"2004","unstructured":"Isenberg, D. A. et al. BILAG. Development and initial validation of an updated version of the British Isles Lupus Assessment Group\u2019s disease activity index for patients with systemic lupus erythematosus. Rheumatology 2005(44), 902\u2013906. https:\/\/doi.org\/10.1093\/rheumatology\/keh624 (2004).","journal-title":"Rheumatology"},{"key":"6170_CR6","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1182\/blood-2009-11-253815","volume":"116","author":"LA Cohen","year":"2010","unstructured":"Cohen, L. A. et al. Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway. Blood 116, 1574\u20131584. https:\/\/doi.org\/10.1182\/blood-2009-11-253815 (2010).","journal-title":"Blood"},{"key":"6170_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34560-7","author":"J Jia","year":"2022","unstructured":"Jia, J. et al. Ferritin triggers neutrophil extracellular trap-mediated cytokine storm through Msr1 contributing to adult-onset Still\u2019s disease pathogenesis. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-022-34560-7 (2022).","journal-title":"Nat. Commun."},{"key":"6170_CR8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.ijpam.2019.07.007","volume":"7","author":"N Almutairi","year":"2020","unstructured":"Almutairi, N. et al. Utility of serum ferritin and soluble interleukin-2 receptor as markers of disease activity in childhood systemic lupus erythematosus. Int. J. Pediatr. Adolesc. Med. 7, 112\u2013115. https:\/\/doi.org\/10.1016\/j.ijpam.2019.07.007 (2020).","journal-title":"Int. J. Pediatr. Adolesc. Med."},{"key":"6170_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/ar4012","author":"K Vanarsa","year":"2012","unstructured":"Vanarsa, K. et al. Inflammation associated anemia and ferritin as disease markers in SLE. Arthr. Res. Ther. https:\/\/doi.org\/10.1186\/ar4012 (2012).","journal-title":"Arthr. Res. Ther."},{"key":"6170_CR10","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1002\/acr.22835","volume":"68","author":"CC Mok","year":"2016","unstructured":"Mok, C. C. et al. Axl, ferritin, insulin-like growth factor binding protein 2, and tumor necrosis factor receptor type II as biomarkers in systemic lupus erythematosus. Arthr. Care Res. 68, 1303\u20131309. https:\/\/doi.org\/10.1002\/acr.22835 (2016).","journal-title":"Arthr. Care Res."},{"key":"6170_CR11","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1021\/acs.jproteome.5b00905","volume":"15","author":"T Wu","year":"2016","unstructured":"Wu, T. et al. Antibody-array-based proteomic screening of serum markers in systemic lupus erythematosus: A discovery study. J. Proteome Res. 15, 2102\u20132114. https:\/\/doi.org\/10.1021\/acs.jproteome.5b00905 (2016).","journal-title":"J. Proteome Res."},{"key":"6170_CR12","first-page":"244","volume":"64","author":"A Ates","year":"2005","unstructured":"Ates, A., Karaaslan, Y. & Ozbalkan, Z. Serum ferritin level as a serologic marker of disease activity and renal involvement in patients with systemic lupus erythematosus. Ann. Rheum. Dis. 64, 244 (2005).","journal-title":"Ann. Rheum. Dis."},{"key":"6170_CR13","first-page":"14","volume":"64","author":"V Pradhan","year":"2016","unstructured":"Pradhan, V. et al. Association of Serum ferritin levels with hematological manifestations in systemic lupus erythematosus patients from western India. J. Assoc. Phys. India 64, 14\u201318 (2016).","journal-title":"J. Assoc. Phys. India"},{"key":"6170_CR14","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1136\/annrheumdis-2012-202449","volume":"72","author":"ME Clowse","year":"2013","unstructured":"Clowse, M. E. et al. Predictors of preterm birth in patients with mild systemic lupus erythematosus. Ann. Rheum. Dis. 72, 1536\u20131539. https:\/\/doi.org\/10.1136\/annrheumdis-2012-202449 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"6170_CR15","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s10067-013-2227-1","volume":"32","author":"S Vilaiyuk","year":"2013","unstructured":"Vilaiyuk, S. et al. Recurrent macrophage activation syndrome as the primary manifestation in systemic lupus erythematosus and the benefit of serial ferritin measurements: A case-based review. Clin. Rheumatol. 32, 899\u2013904. https:\/\/doi.org\/10.1007\/s10067-013-2227-1 (2013).","journal-title":"Clin. Rheumatol."},{"key":"6170_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s12016-011-8264-0","volume":"44","author":"G Zandman-Goddard","year":"2013","unstructured":"Zandman-Goddard, G. et al. Hyperferritinemia is associated with serologic antiphospholipid syndrome in SLE patients. Clin. Rev. Allergy Immunol. 44, 23\u201330. https:\/\/doi.org\/10.1007\/s12016-011-8264-0 (2013).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"6170_CR17","doi-asserted-by":"publisher","first-page":"100150","DOI":"10.1016\/j.jtauto.2022.100150","volume":"5","author":"NP Duarte-Delgado","year":"2022","unstructured":"Duarte-Delgado, N. P. et al. Metabolites and metabolic pathways associated with rheumatoid arthritis and systemic lupus erythematosus. J. Transl. Autoimmun. 5, 100150\u2013100150. https:\/\/doi.org\/10.1016\/j.jtauto.2022.100150 (2022).","journal-title":"J. Transl. Autoimmun."},{"key":"6170_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0224496","author":"SM Hammad","year":"2019","unstructured":"Hammad, S. M. et al. Race disparity in blood sphingolipidomics associated with lupus cardiovascular comorbidity. PLoS ONE https:\/\/doi.org\/10.1371\/journal.pone.0224496 (2019).","journal-title":"PLoS ONE"},{"key":"6170_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.prostaglandins.2019.106348","author":"S Patyna","year":"2019","unstructured":"Patyna, S. et al. Blood ceramides as novel markers for renal impairment in systemic lupus erythematosus. Prostaglandin. Other Lipid Mediat. https:\/\/doi.org\/10.1016\/j.prostaglandins.2019.106348 (2019).","journal-title":"Prostaglandin. Other Lipid Mediat."},{"key":"6170_CR20","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1136\/annrheumdis-2017-212935","volume":"77","author":"PC Grayson","year":"2018","unstructured":"Grayson, P. C. et al. Metabolic pathways and immunometabolism in rare kidney diseases. Ann. Rheum. Dis. 77, 1227. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212935 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"6170_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/cells12162093","author":"H Zhao","year":"2023","unstructured":"Zhao, H., Wen, Z. & Xiong, S. Activated lymphocyte-derived DNA drives glucose metabolic adaptation for inducing macrophage inflammatory response in systemic lupus erythematosus. Cells https:\/\/doi.org\/10.3390\/cells12162093 (2023).","journal-title":"Cells"},{"key":"6170_CR22","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/art.42722","volume":"76","author":"J Peng","year":"2024","unstructured":"Peng, J. et al. Atherosclerosis progression in the APPLE trial can be predicted in young people with juvenile-onset systemic lupus erythematosus using a novel lipid metabolomic signature. Arthr. Rheumatol. 76, 455\u2013468. https:\/\/doi.org\/10.1002\/art.42722 (2024).","journal-title":"Arthr. Rheumatol."},{"key":"6170_CR23","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1002\/art.41419","volume":"72","author":"J Li","year":"2020","unstructured":"Li, J. et al. Taurine metabolism aggravates the progression of lupus by promoting the function of plasmacytoid dendritic cells. Arthr. Rheumatol. 72, 2106\u20132117. https:\/\/doi.org\/10.1002\/art.41419 (2020).","journal-title":"Arthr. Rheumatol."},{"key":"6170_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103243","author":"GA Robinson","year":"2021","unstructured":"Robinson, G. A. et al. Increased apolipoprotein-B:A1 ratio predicts cardiometabolic risk in patients with juvenile onset SLE. EBioMedicine https:\/\/doi.org\/10.1016\/j.ebiom.2021.103243 (2021).","journal-title":"EBioMedicine"},{"key":"6170_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.833699","author":"X Huang","year":"2022","unstructured":"Huang, X. et al. Multi-platform omics analysis reveals molecular signatures for pathogenesis and activity of systemic lupus erythematosus. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.833699 (2022).","journal-title":"Front. Immunol."},{"key":"6170_CR26","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg, M. C. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthr. Rheum. 40, 1725. https:\/\/doi.org\/10.1002\/art.1780400928 (1997).","journal-title":"Arthr. Rheum."},{"key":"6170_CR27","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.cell.2016.03.008","volume":"165","author":"R Banchereau","year":"2016","unstructured":"Banchereau, R. et al. Personalized immunomonitoring uncovers molecular networks that stratify lupus patients. Cell 165, 551\u2013565. https:\/\/doi.org\/10.1016\/j.cell.2016.03.008 (2016).","journal-title":"Cell"},{"key":"6170_CR28","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1186\/s13075-018-1666-0","volume":"20","author":"JA Reynolds","year":"2018","unstructured":"Reynolds, J. A. et al. Cytokine profiling in active and quiescent SLE reveals distinct patient subpopulations. Arthr. Res. Ther. 20, 173. https:\/\/doi.org\/10.1186\/s13075-018-1666-0 (2018).","journal-title":"Arthr. Res. Ther."},{"key":"6170_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12016-015-8473-z","volume":"50","author":"JQ Chen","year":"2016","unstructured":"Chen, J. Q., Szodoray, P. & Zeher, M. Toll-like receptor pathways in autoimmune diseases. Clin. Rev. Allergy Immunol. 50, 1\u201317. https:\/\/doi.org\/10.1007\/s12016-015-8473-z (2016).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"6170_CR30","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.molmed.2016.04.005","volume":"22","author":"N Jourde-Chiche","year":"2016","unstructured":"Jourde-Chiche, N., Chiche, L. & Chaussabel, D. Introducing a new dimension to molecular disease classifications. Trends Mol. Med. 22, 451\u2013453. https:\/\/doi.org\/10.1016\/j.molmed.2016.04.005 (2016).","journal-title":"Trends Mol. Med."},{"key":"6170_CR31","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1046\/j.1523-1755.2003.00881.x","volume":"63","author":"H Peters","year":"2003","unstructured":"Peters, H. et al. L-Arginine supplementation accelerates renal fibrosis and shortens life span in experimental lupus nephritis. Kid. Int. 63, 1382\u20131392. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00881.x (2003).","journal-title":"Kid. Int."},{"key":"6170_CR32","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s13075-020-02264-2","volume":"22","author":"T Zhang","year":"2020","unstructured":"Zhang, T. & Mohan, C. Caution in studying and interpreting the lupus metabolome. Arthr. Res. Ther. 22, 172. https:\/\/doi.org\/10.1186\/s13075-020-02264-2 (2020).","journal-title":"Arthr. Res. Ther."},{"key":"6170_CR33","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1093\/rheumatology\/keaa126","volume":"60","author":"Q Zhang","year":"2021","unstructured":"Zhang, Q. et al. Metabolomic profiling reveals serum L-pyroglutamic acid as a potential diagnostic biomarker for systemic lupus erythematosus. Rheumatology (Oxford) 60, 598\u2013606. https:\/\/doi.org\/10.1093\/rheumatology\/keaa126 (2021).","journal-title":"Rheumatology (Oxford)"},{"key":"6170_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21124501","author":"E Knuplez","year":"2020","unstructured":"Knuplez, E. & Marsche, G. An updated review of pro- and anti-inflammatory properties of plasma lysophosphatidylcholines in the vascular system. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms21124501 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"6170_CR35","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/j.1476-5381.2010.01117.x","volume":"162","author":"ND Hung","year":"2011","unstructured":"Hung, N. D., Kim, M. R. & Sok, D. E. Mechanisms for anti-inflammatory effects of 1-[15(S)-hydroxyeicosapentaenoyl] lysophosphatidylcholine, administered intraperitoneally, in zymosan A-induced peritonitis. Br. J. Pharmacol. 162, 1119\u20131135. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.01117.x (2011).","journal-title":"Br. J. Pharmacol."},{"key":"6170_CR36","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1161\/atvbaha.112.249854","volume":"32","author":"I Gon\u00e7alves","year":"2012","unstructured":"Gon\u00e7alves, I. et al. Evidence supporting a key role of Lp-PLA2-generated lysophosphatidylcholine in human atherosclerotic plaque inflammation. Arterioscler. Thromb. Vasc. Biol. 32, 1505\u20131512. https:\/\/doi.org\/10.1161\/atvbaha.112.249854 (2012).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"6170_CR37","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.cellimm.2014.04.010","volume":"289","author":"X Qin","year":"2014","unstructured":"Qin, X., Qiu, C. & Zhao, L. Lysophosphatidylcholine perpetuates macrophage polarization toward classically activated phenotype in inflammation. Cell. Immunol. 289, 185\u2013190. https:\/\/doi.org\/10.1016\/j.cellimm.2014.04.010 (2014).","journal-title":"Cell. Immunol."},{"key":"6170_CR38","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s10020-024-00866-z","volume":"30","author":"L Zhao","year":"2024","unstructured":"Zhao, L. et al. Regulation of macrophage polarization by targeted metabolic reprogramming for the treatment of lupus nephritis. Mol. Med. 30, 96. https:\/\/doi.org\/10.1186\/s10020-024-00866-z (2024).","journal-title":"Mol. Med."},{"key":"6170_CR39","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1080\/03009742.2021.1923183","volume":"51","author":"D Gorczyca","year":"2022","unstructured":"Gorczyca, D. et al. Serum levels of n-3 and n-6 polyunsaturated fatty acids in patients with systemic lupus erythematosus and their association with disease activity: A pilot study. Scand. J. Rheumatol. 51, 230\u2013236. https:\/\/doi.org\/10.1080\/03009742.2021.1923183 (2022).","journal-title":"Scand. J. Rheumatol."},{"key":"6170_CR40","doi-asserted-by":"publisher","first-page":"1459297","DOI":"10.3389\/fimmu.2024.1459297","volume":"15","author":"KN Gilley","year":"2024","unstructured":"Gilley, K. N. et al. Serum fatty acid profiles in systemic lupus erythematosus and patient reported outcomes: The Michigan lupus epidemiology and surveillance (MILES) program. Front. Immunol. 15, 1459297. https:\/\/doi.org\/10.3389\/fimmu.2024.1459297 (2024).","journal-title":"Front. Immunol."},{"key":"6170_CR41","doi-asserted-by":"publisher","first-page":"7380","DOI":"10.26355\/eurrev_202308_33310","volume":"27","author":"R Poggioli","year":"2023","unstructured":"Poggioli, R. et al. Modulation of inflammation and immunity by omega-3 fatty acids: a possible role for prevention and to halt disease progression in autoimmune, viral, and age-related disorders. Eur. Rev. Med. Pharmacol. Sci. 27, 7380\u20137400. https:\/\/doi.org\/10.26355\/eurrev_202308_33310 (2023).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"6170_CR42","doi-asserted-by":"publisher","first-page":"783338","DOI":"10.3389\/fnut.2022.783338","volume":"9","author":"P Wang","year":"2022","unstructured":"Wang, P. et al. Genetically predicted circulating omega-3 fatty acids levels are causally associated with increased risk for systemic lupus erythematosus. Front. Nutr. 9, 783338. https:\/\/doi.org\/10.3389\/fnut.2022.783338 (2022).","journal-title":"Front. Nutr."},{"key":"6170_CR43","doi-asserted-by":"publisher","first-page":"114732","DOI":"10.1016\/j.bcp.2021.114732","volume":"192","author":"ML Alvarez","year":"2021","unstructured":"Alvarez, M. L. & Lorenzetti, F. Role of eicosanoids in liver repair, regeneration and cancer. Biochem. Pharmacol. 192, 114732. https:\/\/doi.org\/10.1016\/j.bcp.2021.114732 (2021).","journal-title":"Biochem. Pharmacol."},{"key":"6170_CR44","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41591-018-0254-9","volume":"25","author":"S Caielli","year":"2019","unstructured":"Caielli, S. et al. A CD4(+) T cell population expanded in lupus blood provides B cell help through interleukin-10 and succinate. Nat. Med. 25, 75\u201381. https:\/\/doi.org\/10.1038\/s41591-018-0254-9 (2019).","journal-title":"Nat. Med."},{"key":"6170_CR45","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.tcb.2023.10.005","volume":"34","author":"CG Peace","year":"2024","unstructured":"Peace, C. G., O\u2019Carroll, S. M. & O\u2019Neill, L. A. J. Fumarate hydratase as a metabolic regulator of immunity. Trends Cell. Biol. 34, 442\u2013450. https:\/\/doi.org\/10.1016\/j.tcb.2023.10.005 (2024).","journal-title":"Trends Cell. Biol."},{"key":"6170_CR46","doi-asserted-by":"publisher","first-page":"6601","DOI":"10.1073\/pnas.1424638112","volume":"112","author":"RS Jansen","year":"2015","unstructured":"Jansen, R. S. et al. N-lactoyl-amino acids are ubiquitous metabolites that originate from CNDP2-mediated reverse proteolysis of lactate and amino acids. Proc. Natl. Acad. Sci. U. S. A. 112, 6601\u20136606. https:\/\/doi.org\/10.1073\/pnas.1424638112 (2015).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"6170_CR47","doi-asserted-by":"publisher","first-page":"4140","DOI":"10.1021\/ac1003213","volume":"82","author":"TD Horvath","year":"2010","unstructured":"Horvath, T. D. et al. Quantitative measurement of plasma 3-hydroxyisovaleryl carnitine by LC-MS\/MS as a novel biomarker of biotin status in humans. Anal. Chem. 82, 4140\u20134144. https:\/\/doi.org\/10.1021\/ac1003213 (2010).","journal-title":"Anal. Chem."},{"key":"6170_CR48","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.3945\/ajcn.110.002543","volume":"92","author":"SL Stratton","year":"2010","unstructured":"Stratton, S. L. et al. Plasma concentration of 3-hydroxyisovaleryl carnitine is an early and sensitive indicator of marginal biotin deficiency in humans. Am. J. Clin. Nutr. 92, 1399\u20131405. https:\/\/doi.org\/10.3945\/ajcn.110.002543 (2010).","journal-title":"Am. J. Clin. Nutr."},{"key":"6170_CR49","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1001\/jamacardio.2017.1239","volume":"2","author":"H Wang","year":"2017","unstructured":"Wang, H. et al. Sildenafil treatment in heart failure with preserved ejection fraction targeted metabolomic profiling in the RELAX trial. Jama Cardiol. 2, 896\u2013901. https:\/\/doi.org\/10.1001\/jamacardio.2017.1239 (2017).","journal-title":"Jama Cardiol."},{"key":"6170_CR50","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aax2220","author":"S-C Choi","year":"2020","unstructured":"Choi, S.-C. et al. Gut microbiota dysbiosis and altered tryptophan catabolism contribute to autoimmunity in lupus-susceptible mice. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.aax2220 (2020).","journal-title":"Sci. Transl. Med."},{"key":"6170_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00976","author":"Q Zhang","year":"2019","unstructured":"Zhang, Q. et al. Fecal metabolomics and potential biomarkers for systemic lupus erythematosus. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2019.00976 (2019).","journal-title":"Front. Immunol."},{"key":"6170_CR52","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kead402","author":"Y Kaneko","year":"2023","unstructured":"Kaneko, Y. et al. Pathogenetic associations of anti-ribosomal P protein antibody titres and its subclasses in patients with systemic lupus erythematosus. Rheumatology (Oxford) https:\/\/doi.org\/10.1093\/rheumatology\/kead402 (2023).","journal-title":"Rheumatology (Oxford)"},{"key":"6170_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2023.09.003","author":"Z Gan","year":"2023","unstructured":"Gan, Z. et al. Carbon metabolism in the regulation of macrophage functions. Trends Endocrinol. Metab.: TEM https:\/\/doi.org\/10.1016\/j.tem.2023.09.003 (2023).","journal-title":"Trends Endocrinol. Metab.: TEM"},{"key":"6170_CR54","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.gene.2013.11.094","volume":"536","author":"Y Rupasree","year":"2014","unstructured":"Rupasree, Y. et al. Epigenetic modulation of RFC1, MHC2TA and HLA-DR in systemic lupus erythematosus: Association with serological markers and six functional polymorphisms of one-carbon metabolic pathway. Gene 536, 45\u201352. https:\/\/doi.org\/10.1016\/j.gene.2013.11.094 (2014).","journal-title":"Gene"},{"key":"6170_CR55","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.4049\/jimmunol.2000672","volume":"206","author":"Y Kushnareva","year":"2021","unstructured":"Kushnareva, Y. et al. Functional analysis of immune signature genes in Th1*memory cells links ISOC1 and pyrimidine metabolism to IFN-\u03b3 and IL-17 production. J. Immunol. 206, 1181\u20131193. https:\/\/doi.org\/10.4049\/jimmunol.2000672 (2021).","journal-title":"J. Immunol."},{"key":"6170_CR56","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1124\/pr.57.2.3","volume":"57","author":"BN Cronstein","year":"2005","unstructured":"Cronstein, B. N. Low-dose methotrexate: A mainstay in the treatment of rheumatoid arthritis. Pharmacol. Rev. 57, 163\u2013172. https:\/\/doi.org\/10.1124\/pr.57.2.3 (2005).","journal-title":"Pharmacol. Rev."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06170-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06170-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06170-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T04:44:13Z","timestamp":1752554653000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06170-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,15]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6170"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-06170-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,15]]},"assertion":[{"value":"22 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All participants gave their written Informed consent approved by the Ethics Committee of the Drum Tower Clinical Medical School of Nanjing Medical University in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"25481"}}